HAMASHIMA Yoshio | Department of Pharmaceutical Manufacturing Chemistry, 21st Century COE Program, Kyoto Pharmaceutical
スポンサーリンク
概要
- 同名の論文著者
- Department of Pharmaceutical Manufacturing Chemistry, 21st Century COE Program, Kyoto Pharmaceuticalの論文著者
関連著者
-
Katoh Takahiro
Department Of Pharmaceutical Manufacturing Chemistry 21st Century Coe Program Kyoto Pharmaceutical U
-
梶本 哲也
京都薬大
-
KAJIMOTO Tetsuya
Department of Pharmaceutical Manufacturing Chemistry, Kyoto Pharmaceutical University
-
NODE Manabu
Department of Pharmaceutical Manufacturing Chemistry, Kyoto Pharmaceutical University
-
Node Manabu
Department Of Pharmaceutical Manufacturing Chemistry 21st Century Coe Program Kyoto Pharmaceutical U
-
Node M
Department Of Pharmaceutical Manufacturing Chemistry 21st Century Coe Program Kyoto Pharmaceutical U
-
Node Manabu
Kyoto Pharmaceutical Univ.
-
Node Manabu
Department Of Pharmaceutical Manufacturing Chemistry Kyoto Pharmaceutical University
-
Katoh Takahiro
Department Of Pharmaceutical Manufacturing Chemistry Kyoto Pharmaceutical University
-
HAMASHIMA Yoshio
Department of Pharmaceutical Manufacturing Chemistry, 21st Century COE Program, Kyoto Pharmaceutical
-
Kajimoto Tetsuya
Department Of Biotechnology Tokyo University Of Agriculture And Technology
-
Kajimoto Tetsuya
Department Of Pharmaceutical Manufacturing Chemistry Kyoto Pharmaceutical University
-
Hamashima Yoshio
Department Of Pharmaceutical Manufacturing Chemistry 21st Century Coe Program Kyoto Pharmaceutical U
-
Node Manabu
Department Of Pharmaceutical Manufacturing Chemistry 21st Century Coe Program Kyoto Pharmaceutical U
-
Kato Takahiro
Department Of Pharmaceutical Manufacturing Chemistry Kyoto Pharmaceutical University
-
Katoh Takahiro
Department of Cardiology, Edogawa Hospital
-
MIYAZONO Kohei
Department of Molecular Pathology, Graduate School of Medicine, University of Tokyo
-
Saitoh Masao
Department of Internal Medicine, Sapporo Hokuyu Hospital, Artificial Organ & Transplantation Hospita
-
Imamura Takeshi
Department Of Biochemistry The Cancer Institute Of The Japanese Foundation For Cancer Research (jfcr
-
Imamura Takeshi
Department Of Biochemistry The Cancer Institute Of The Japanese Foundation For Cancer Research
-
Saitoh Masao
Department Of Molecular Pathology Graduate School Of Medicine University Of Tokyo
-
Miyazono K
Department Of Biochemistry The Cancer Institute Of The Japanese Foundation For Cancer Research(jfcr)
-
NISHIDE Kiyoharu
Department of Pharmaceutical Manufacturing Chemistry, 21st Century COE Program, Kyoto Pharmaceutical
-
Hanyu Aki
Department Of Biochemistry The Cancer Institute Of The Japanese Foundation For Cancer Research (jfcr
-
KODAMA Sumiaki
Department of Pharmaceutical Manufacturing Chemistry, 21st Century COE Program, Kyoto Pharmaceutical
-
Kodama Sumiaki
Department Of Pharmaceutical Manufacturing Chemistry 21st Century Coe Program Kyoto Pharmaceutical U
-
TOJO Masayoshi
Department of Biochemistry, The Cancer Institute of the Japanese Foundation for Cancer Research (JFC
-
Tojo Masayoshi
Department Of Biochemistry The Cancer Institute Of The Japanese Foundation For Cancer Research (jfcr
-
Miyazono Kohei
Department Of Biochemistry Cancer Institute Of The Japanese Foundation For Cancer Research (jfcr)
-
Nishide Kiyoharu
Department Of Pharmaceutical Manufacturing Chemistry 21st Century Coe Program Kyoto Pharmaceutical U
-
Nishide K
Kyoto Pharmaceutical University
-
Miyazono Kohei
Univ. Tokyo Tokyo Jpn
-
Saitoh Masao
Department Of Biochemistry Interdisciplinary Graduate School Of Medicine And Engineering University
-
Imamura Takeshi
Department Of Applied Physics Faculty Of Science Tokyo Institute Of Technology:(present Address) Fuj
-
Nishide Kiyoharu
Department Of Pharmaceutical Manufacturing Chemistry 21st Century Coe Program Kyoto Pharmaceutical U
著作論文
- Biomimetic Synthesis of (±)-Galanthamine and Asymmetric Synthesis of (-)-Galanthamine Using Remote Asymmetric Induction
- The ALK-5 inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-β